On January 18, 2016, Soren Mogelsvang resigned as President and Chief Executive Officer of Peak Pharmaceuticals, Inc. Following his resignation as an officer, Mr. Mogelsvang continues to serve as a member of the company's board of directors. Following the resignation of Mr. Mogelsvang as President and Chief Executive Officer of the company. on January 19, 2016, the Board of Directors appointed Arnold Tinter as President and Chief Executive Officer of the company.

Mr. Tinter was appointed as the company's Chief Financial Officer, Secretary and Treasury on October 15, 2013, and, in addition to his appointment as President and Chief Executive Officer, continues to hold those positions.